The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Balaji Amines Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals, aliphatic amines and derivatives. The Company’s segments include Amines & Specialty Chemicals and Hotel Division. It also owns a five-star Hotel in…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A middling, stagnant business, priced for perfection.
Balaji Amines is scored on the general / industrial framework. It keeps a healthy 11.6% of every rupee of sales as net profit. Cash broadly tracks reported profit (CFO/PAT 1.09×). Free cash flow is worth about -1.9% of its market value.
Over the last 3 years revenue compounded at -15%/yr and profit at -25%/yr. Book value has grown 8%/yr. Return on equity is a modest 8.5%. In the latest quarter profit grew 21% versus the prior quarter.
At 50× earnings, the stock sits at the 100th percentile of its own 3.5-year range — the expensive end of where it has historically traded. Today's price already implies ~18%/yr earnings growth sustained for a decade — a demanding bar. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 39.45 | 26.39 | worse |
| P/B | 4.21 | 3.01 | worse |
| EV/EBITDA | 22.86 | — | — |
| ROE | 8.46 | — | — |
| ROCE | 11.24 | — | — |
| ROA | 7.68 | — | — |
| Quick Ratio | 1.73 | 2.69 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Pidilite Industries | 60.3 | 14.9 | 22.6% |
| SRF | 34.8 | 5.4 | 13.1% |
| Linde India | 99.3 | 12.7 | 12.9% |
Negative CAGR — the top line has shrunk over this window. Growth is accelerating — latest year outpaced the prior year's rate.
Revenue is outpacing profit (-15% vs -25%) — costs are rising faster than the top line.
Operating margin has compressed from 24% to 16% — costs or competition are eating into profitability. Interest or tax burden is shrinking — more of the operating profit is reaching the bottom line. Margins have declined for 2 consecutive years — watch for a structural cost problem.
ROE at 8% — modest; the capital isn't working hard. Capital efficiency declining — ROE down 16pp.
EPS outpaced profit growth — possible buybacks are concentrating earnings into fewer shares. -20% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
Operating cash flow has been positive every year — the business generates real cash, not just accounting profit. Investing outflows exceed operating cash — the company relies on external funding to finance expansion. Raising capital despite positive cash flow — could signal expansion plans or opportunistic fundraising.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 15% sequentially — momentum is building. Run-rate stepping up — recent quarters average 26% above earlier ones.
Profit jumped 21% QoQ — check if this is operating leverage or a one-off item. Quarterly net margins are expanding (11% → 17%) — profitability per rupee of revenue is improving.
How today's P/E compares to the stock's own historical range. Dashed line = the 3.5y median.
Promoter holding at 54.6% — majority control intact.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.